語系:
繁體中文
English
日文
簡体中文
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Medication-related osteonecrosis of ...
~
Otto, Sven.
Medication-related osteonecrosis of the jaws[electronic resource] :bisphosphonates, denosumab, and new agents /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
杜威分類號:
615.7042
書名/作者:
Medication-related osteonecrosis of the jaws : bisphosphonates, denosumab, and new agents // edited by Sven Otto.
其他作者:
Otto, Sven.
出版者:
Berlin, Heidelberg : : Springer Berlin Heidelberg :, 2015.
面頁冊數:
viii, 220 p. : : ill. (some col.), digital ;; 24 cm.
Contained By:
Springer eBooks
標題:
Jaws - Necrosis.
標題:
Cancer - Chemotherapy
標題:
Osteoporosis - Chemotherapy
標題:
Medicine & Public Health.
標題:
Oral and Maxillofacial Surgery.
標題:
Dentistry.
ISBN:
9783662437339 (electronic bk.)
ISBN:
9783662437322 (paper)
內容註:
Pharmacology of Antiresorptive Drugs -- The Role of Antiresorptive Drugs in the Treatment of Osteoporosis -- The Role of Antiresorptive Drugs in the Treatment of Skeletal Manifestations of Malignant Diseases -- Clinical Features, Localization, Definition and Staging of the Disease -- Radiological Findings / Imaging -- General Characteristics and Risk Factors for BRONJ -- Epidemiology -- Histopathology of BRONJ -- Prevention of Osteonecrosis and Dentoalveolar Surgery Under Treatment With Antiresorptive Drugs -- Bisphosphonates and Dental Implants -- Treatment of BRONJ -- Local and Microvascular Flaps in ONJ-Treatment -- Rehabilitation of Patients After BRONJ -- Adjuvant Treatment Strategies -- Microbiology and Antibiotics -- Animal Models of ONJ -- ONJ Under Denosumab and Other New Drugs -- Possible Use of Antiresorptive Drugs in OMS -- Dental Treatment Under BPs and After BRONJ -- Dental Rehabilitation Under Bisphosphonates and After BRONJ -- History of ONJ.
摘要、提要註:
Osteonecrosis of the jaws is a well-known side-effect of antiresorptive therapy that predominantly occurs in patients suffering from malignant diseases and receiving intravenous administrations of nitrogen-containing bisphosphonates or subcutaneous administrations of denosumab, a monoclonal antibody. Less frequently it may also be observed in patients with osteoporosis who are being treated with these antiresorptive drugs. This textbook provides detailed, up-to-date information on all aspects of medication-related osteonecrosis of the jaws, including clinical features, pathogenesis, treatment options, and preventive measures. It also explains safe prevention and treatment strategies for patients receiving antiresorptive drugs who require extractions, implant insertions, and other dento-alveolar surgeries. This book will be of major interest for medical and dental students, dentists, and oral and maxillofacial surgeons as well as osteologists and oncologists.
電子資源:
http://dx.doi.org/10.1007/978-3-662-43733-9
Medication-related osteonecrosis of the jaws[electronic resource] :bisphosphonates, denosumab, and new agents /
Medication-related osteonecrosis of the jaws
bisphosphonates, denosumab, and new agents /[electronic resource] :edited by Sven Otto. - Berlin, Heidelberg :Springer Berlin Heidelberg :2015. - viii, 220 p. :ill. (some col.), digital ;24 cm.
Pharmacology of Antiresorptive Drugs -- The Role of Antiresorptive Drugs in the Treatment of Osteoporosis -- The Role of Antiresorptive Drugs in the Treatment of Skeletal Manifestations of Malignant Diseases -- Clinical Features, Localization, Definition and Staging of the Disease -- Radiological Findings / Imaging -- General Characteristics and Risk Factors for BRONJ -- Epidemiology -- Histopathology of BRONJ -- Prevention of Osteonecrosis and Dentoalveolar Surgery Under Treatment With Antiresorptive Drugs -- Bisphosphonates and Dental Implants -- Treatment of BRONJ -- Local and Microvascular Flaps in ONJ-Treatment -- Rehabilitation of Patients After BRONJ -- Adjuvant Treatment Strategies -- Microbiology and Antibiotics -- Animal Models of ONJ -- ONJ Under Denosumab and Other New Drugs -- Possible Use of Antiresorptive Drugs in OMS -- Dental Treatment Under BPs and After BRONJ -- Dental Rehabilitation Under Bisphosphonates and After BRONJ -- History of ONJ.
Osteonecrosis of the jaws is a well-known side-effect of antiresorptive therapy that predominantly occurs in patients suffering from malignant diseases and receiving intravenous administrations of nitrogen-containing bisphosphonates or subcutaneous administrations of denosumab, a monoclonal antibody. Less frequently it may also be observed in patients with osteoporosis who are being treated with these antiresorptive drugs. This textbook provides detailed, up-to-date information on all aspects of medication-related osteonecrosis of the jaws, including clinical features, pathogenesis, treatment options, and preventive measures. It also explains safe prevention and treatment strategies for patients receiving antiresorptive drugs who require extractions, implant insertions, and other dento-alveolar surgeries. This book will be of major interest for medical and dental students, dentists, and oral and maxillofacial surgeons as well as osteologists and oncologists.
ISBN: 9783662437339 (electronic bk.)
Standard No.: 10.1007/978-3-662-43733-9doiSubjects--Topical Terms:
465924
Jaws
--Necrosis.
LC Class. No.: RC936
Dewey Class. No.: 615.7042
Medication-related osteonecrosis of the jaws[electronic resource] :bisphosphonates, denosumab, and new agents /
LDR
:02923nam a2200313 a 4500
001
425717
003
DE-He213
005
20150724155644.0
006
m d
007
cr nn 008maaau
008
151119s2015 gw s 0 eng d
020
$a
9783662437339 (electronic bk.)
020
$a
9783662437322 (paper)
024
7
$a
10.1007/978-3-662-43733-9
$2
doi
035
$a
978-3-662-43733-9
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC936
072
7
$a
MMDS
$2
bicssc
072
7
$a
MED085020
$2
bisacsh
082
0 4
$a
615.7042
$2
23
090
$a
RC936
$b
.M489 2015
245
0 0
$a
Medication-related osteonecrosis of the jaws
$h
[electronic resource] :
$b
bisphosphonates, denosumab, and new agents /
$c
edited by Sven Otto.
260
$a
Berlin, Heidelberg :
$b
Springer Berlin Heidelberg :
$b
Imprint: Springer,
$c
2015.
300
$a
viii, 220 p. :
$b
ill. (some col.), digital ;
$c
24 cm.
505
0
$a
Pharmacology of Antiresorptive Drugs -- The Role of Antiresorptive Drugs in the Treatment of Osteoporosis -- The Role of Antiresorptive Drugs in the Treatment of Skeletal Manifestations of Malignant Diseases -- Clinical Features, Localization, Definition and Staging of the Disease -- Radiological Findings / Imaging -- General Characteristics and Risk Factors for BRONJ -- Epidemiology -- Histopathology of BRONJ -- Prevention of Osteonecrosis and Dentoalveolar Surgery Under Treatment With Antiresorptive Drugs -- Bisphosphonates and Dental Implants -- Treatment of BRONJ -- Local and Microvascular Flaps in ONJ-Treatment -- Rehabilitation of Patients After BRONJ -- Adjuvant Treatment Strategies -- Microbiology and Antibiotics -- Animal Models of ONJ -- ONJ Under Denosumab and Other New Drugs -- Possible Use of Antiresorptive Drugs in OMS -- Dental Treatment Under BPs and After BRONJ -- Dental Rehabilitation Under Bisphosphonates and After BRONJ -- History of ONJ.
520
$a
Osteonecrosis of the jaws is a well-known side-effect of antiresorptive therapy that predominantly occurs in patients suffering from malignant diseases and receiving intravenous administrations of nitrogen-containing bisphosphonates or subcutaneous administrations of denosumab, a monoclonal antibody. Less frequently it may also be observed in patients with osteoporosis who are being treated with these antiresorptive drugs. This textbook provides detailed, up-to-date information on all aspects of medication-related osteonecrosis of the jaws, including clinical features, pathogenesis, treatment options, and preventive measures. It also explains safe prevention and treatment strategies for patients receiving antiresorptive drugs who require extractions, implant insertions, and other dento-alveolar surgeries. This book will be of major interest for medical and dental students, dentists, and oral and maxillofacial surgeons as well as osteologists and oncologists.
650
0
$a
Jaws
$x
Necrosis.
$3
465924
650
0
$a
Cancer
$x
Chemotherapy
$x
Complications.
$3
559465
650
0
$a
Osteoporosis
$x
Chemotherapy
$x
Complications.
$3
604972
650
1 4
$a
Medicine & Public Health.
$3
463493
650
2 4
$a
Oral and Maxillofacial Surgery.
$3
464201
650
2 4
$a
Dentistry.
$3
461354
700
1
$a
Otto, Sven.
$3
604971
710
2
$a
SpringerLink (Online service)
$3
463450
773
0
$t
Springer eBooks
856
4 0
$u
http://dx.doi.org/10.1007/978-3-662-43733-9
950
$a
Medicine (Springer-11650)
筆 0 讀者評論
多媒體
多媒體檔案
http://dx.doi.org/10.1007/978-3-662-43733-9
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入